1,2,7,8-tetrachlorodibenzo-p-dioxin has been researched along with harmaline in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Denison, MS; El Gendy, MA; El-Kadi, AO; Soshilov, AA | 1 |
1 other study(ies) available for 1,2,7,8-tetrachlorodibenzo-p-dioxin and harmaline
Article | Year |
---|---|
Harmaline and harmalol inhibit the carcinogen-activating enzyme CYP1A1 via transcriptional and posttranslational mechanisms.
Topics: Cytochrome P-450 CYP1A1; Dioxins; Gene Expression Regulation, Enzymologic; Harmaline; Hep G2 Cells; Humans; Molecular Structure; Polychlorinated Dibenzodioxins; Protein Processing, Post-Translational; Receptors, Aryl Hydrocarbon; Transcription, Genetic | 2012 |